Survival TrainingNCT02503007
Effects of 14-days of HMB-free Acid on Changes in Muscle During 4-days of Survival Training
A study testing HMB-FA in people with Survival Training, run by Metabolic Technologies Inc. at 1 site in Israel.
Trial summary
Sustained high-intensity activity, such as survival training with little nourishment available, can result in a loss of muscle performance. This study will examine the effects of a nutritional supplement to maintain muscle and muscle performance during this period. Read more about this study
- Who is it for?
- Ages 18 to 27 yearsHealthy volunteers can take part
- Conditions the study is for
- Survival Training
- What is being tested?
- HMB-FA
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 27 participants
- Where
- 1 siteIsrael
- Study dates
- Jul 2015to Oct 2015
- Phase
- Interventional
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 27 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- 18 to 27 Years of age
- Soldier members of Special Operations
- Healthy as assessed by the Unit's Medical Officers
- Subject provides written and dated informed consent to participate
Who cannot join
- A history of medical or surgical events that may significantly affect the study outcome, including cardiovascular disease, metabolic, renal, hepatic, or musculoskeletal disorders
- Use of medications that may affect the study outcomes
- Use of nutritional supplements (such as protein drinks, creatine, HMB and vitamins) in the 3 months prior to the start of the study
- Subject is currently participating in another clinical trial or has received an investigational product within thirty days prior to screening/enrollment
Trial locations and contacts
1 site in 1 country.
About this study
Official title: The Effects of 14-days of HMB-Free Acid on Changes in Muscle Architecture, Blood Markers of Muscle Damage and Performance During 4-Days of Survival Training
Sustained high-intensity activity, such as survival training with little nourishment available, can result in a loss of muscle performance. This study will examine the effects of a nutritional supplement to maintain muscle and muscle performance during this period.
Read the detailed description
Sustained high intensity activity that is often accompanied by sleep and nutrient deprivation is a common characteristic of survival training. Survival training is a requirement in the preparation of pilots, where they learn evasion and survival skills that they may need to avoid capture in a situation in which they have bailed from their plane. The physiological stresses associated with the nature of these operations often results in significant decrements in lean body mass, muscle size and muscle endurance and power. During a sudden evacuation from the aircraft the pilot only takes a small survival bag. There is a limit to what can possibly be put in this bag. However, the ability to provide a dietary supplement specifically targeting muscle may provide an important resource for maintaining muscle mass and performance. Thus, the purpose of this study is to determine the efficacy of 14 days of HMB-FA ingestion on maintaining muscle architecture and muscle performance during 4-days of survival training. In addition, anabolic and catabolic markers of stress, inflammation and muscle damage will be assessed.
- Conditions
- Survival Training
- Being tested
- Placebo, HMB-FA
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
PlaceboDietary supplement
HMB-FADietary supplement
Also called beta-hydroxy-beta-methylbutyric acid
| Study group | Role | What they receive |
|---|---|---|
| Placebo | Placebo comparator | A placebo similar in composition and appearance to the experimental treatment. Receives: Dietary Supplement: Placebo |
| HMB-FA | Experimental | Active treatment consisting of 3 g of HMB-FA per day. Receives: Dietary Supplement: HMB-FA |
What is being measured
The primary outcome is the main question the study is designed to answer.
Muscle Strength
Hand grip strength will be measured using a hand-grip dynamometer.
Measured: Day 18
Secondary outcomes (5)
Muscle Power
Vertical Jump power will be measured using a linear transducer.
Measured: Day 18
Muscle Morphology
Muscle morphology will be measured using a 3.0 Tesla Magnetic Resonance Imaging device.
Measured: Day 18
Muscle Mass
Muscle mass will be performed using bioelectrical impedance
Measured: Day 18
Blood Biochemical Analysis
Blood biochemical analysis will be performed using an ELISA assay.
Measured: Day 18
Urine Biochemical Analysis
Urine biochemical analysis will be performed using an ELISA assay.
Measured: Day 18
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted20 Jul 2015 (estimated)
- Study startJul 2015
- Primary completionSep 2015
- Study completionOct 2015
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Survival TrainingStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Basic science
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Triple blind
- Who is masked
- Participant, Care provider, Investigator
- Enrolment
- 27 participants (actual)
Sponsor and investigators
- Lead sponsor
- Metabolic Technologies Inc.
- Sponsor type
- Industry (pharma, biotech, devices)
- Collaborators
- Koach Sport and Nutrition
- Responsible party
- Sponsor
- Investigators
- Ishay Osterfeld, MD, Principal investigator, International Diabetes Federation
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02503007
- Sponsor's protocol ID
- MTI2015-CS01
- Status last verified
- Oct 2015
- First submitted
- 15 Jul 2015
- Last updated
- 25 Nov 2015
- Results posted
- No
- Data monitoring committee
- No